{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:44Z","timestamp":1793395004660,"version":"4.5.0"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41582-025-01159-7","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:12:32Z","timestamp":1763075552000},"page":"5-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Huntington disease: somatic expansion, pathobiology and therapeutics"],"prefix":"10.1038","volume":"22","author":[{"given":"Jasmine","family":"Donaldson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davina","family":"Hensman Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ciosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Usdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-4468","authenticated-orcid":false,"given":"Gabriel","family":"Balmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-8264","authenticated-orcid":false,"given":"Darren G.","family":"Monckton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-2045","authenticated-orcid":false,"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"1159_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew, S. E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat. Genet. 4, 398\u2013403 (1993).","journal-title":"Nat. Genet."},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat. Genet. 4, 387\u2013392 (1993).","journal-title":"Nat. Genet."},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell, R. G. et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat. Genet. 4, 393\u2013397 (1993).","journal-title":"Nat. Genet."},{"key":"1159_CR5","first-page":"1202","volume":"60","author":"RR Brinkman","year":"1997","unstructured":"Brinkman, R. R., Mezei, M. M., Theilmann, J., Almqvist, E. & Hayden, M. R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet. 60, 1202\u20131210 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JPG Vonsattel","year":"1998","unstructured":"Vonsattel, J. P. G. & Difiglia, M. Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369\u2013384 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1159_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel, J.-P. et al. Neuropathological classification of Huntington\u2019s disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-231523","volume":"13","author":"M Oosterloo","year":"2024","unstructured":"Oosterloo, M. et al. Clinical review of Juvenile Huntington\u2019s disease. J. Huntingtons Dis. 13, 149\u2013161 (2024).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","volume":"84","author":"SJW Evans","year":"2013","unstructured":"Evans, S. J. W. et al. Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records. J. Neurol. Neurosurg. Psychiatry 84, 1156\u20131160 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ejhg.2010.229","volume":"19","author":"SC Warby","year":"2011","unstructured":"Warby, S. C. et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur. J. Hum. Genet. 19, 561\u2013566 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"1159_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000444020","volume":"46","author":"FK Baine","year":"2016","unstructured":"Baine, F. K., Krause, A. & Greenberg, L. J. The frequency of Huntington disease and Huntington disease-like 2 in the South African population. Neuroepidemiology 46, 198\u2013202 (2016).","journal-title":"Neuroepidemiology"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41591-024-03190-5","volume":"30","author":"K Iba\u00f1ez","year":"2024","unstructured":"Iba\u00f1ez, K. et al. Increased frequency of repeat expansion mutations across different populations. Nat. Med. 30, 3357\u20133368 (2024).","journal-title":"Nat. Med."},{"key":"1159_CR13","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4161\/cc.20423","volume":"11","author":"T Ratovitski","year":"2012","unstructured":"Ratovitski, T. et al. Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11, 2006\u20132021 (2012).","journal-title":"Cell Cycle"},{"key":"1159_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","volume":"7","author":"JK Cooper","year":"1998","unstructured":"Cooper, J. K. et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783\u2013790 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR15","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"1159_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2024.11.038","volume":"188","author":"RE Handsaker","year":"2025","unstructured":"Handsaker, R. E. et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington\u2019s disease. Cell 188, 623\u2013639 (2025).","journal-title":"Cell"},{"key":"1159_CR18","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet. 12, 3359\u20133367 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41588-024-01653-6","volume":"56","author":"K M\u00e4tlik","year":"2024","unstructured":"M\u00e4tlik, K. et al. Cell-type-specific CAG repeat expansions and toxicity of mutant huntingtin in human striatum and cerebellum. Nat. Genet. 56, 383\u2013394 (2024).","journal-title":"Nat. Genet."},{"key":"1159_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.neuron.2023.12.009","volume":"112","author":"C Pressl","year":"2024","unstructured":"Pressl, C. et al. Selective vulnerability of layer 5a corticostriatal neurons in Huntington\u2019s disease. Neuron 112, 924\u2013941 (2024).","journal-title":"Neuron"},{"key":"1159_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/hmg\/ddm054","volume":"16","author":"PF Shelbourne","year":"2007","unstructured":"Shelbourne, P. F. et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum. Mol. Genet. 16, 1133\u20131142 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami, M. et al. Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum. Mol. Genet. 18, 3039\u20133047 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"GeM-HD","year":"2015","unstructured":"GeM-HD Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162, 516\u2013526 (2015).","journal-title":"Cell"},{"key":"1159_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"GeM-HD","year":"2019","unstructured":"GeM-HD CAG repeat not polyglutamine length determines timing of Huntington\u2019s disease onset. Cell 178, 887\u2013900 (2019).","journal-title":"Cell"},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41588-025-02191-5","volume":"57","author":"GeM-HD","year":"2025","unstructured":"GeM-HD Genetic modifiers of somatic expansion and clinical phenotypes in Huntington\u2019s disease highlight shared and tissue-specific effects. Nat. Genet. 57, 1426\u20131436 (2025).","journal-title":"Nat. Genet."},{"key":"1159_CR26","doi-asserted-by":"publisher","first-page":"32368","DOI":"10.1074\/jbc.274.45.32368","volume":"274","author":"M R\u00e4schle","year":"1999","unstructured":"R\u00e4schle, M., Marra, G., Nystr\u00f6m-Lahti, M., Sch\u00e4r, P. & Jiricny, J. Identification of hMutL\u03b2, a heterodimer of hMLH1 and hPMS1. J. Biol. Chem. 274, 32368\u201332375 (1999).","journal-title":"J. Biol. Chem."},{"key":"1159_CR27","unstructured":"Paulson, H. in Handbook of Clinical Neurology Vol. 147 (eds Geschwind, D. H. et al.) 105\u2013123 (Elsevier, 2018)."},{"key":"1159_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/ETLS20230015","volume":"7","author":"S Rajagopal","year":"2023","unstructured":"Rajagopal, S., Donaldson, J., Flower, M., Hensman Moss, D. J. & Tabrizi, S. J. Genetic modifiers of repeat expansion disorders. Emerg. Top. Life Sci. 7, 325\u2013337 (2023).","journal-title":"Emerg. Top. Life Sci."},{"key":"1159_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ng1095-115","volume":"11","author":"MA Andrade","year":"1995","unstructured":"Andrade, M. A. & Bork, P. HEAT repeats in the Huntington\u2019s disease protein. Nat. Genet. 11, 115\u2013116 (1995).","journal-title":"Nat. Genet."},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature25502","volume":"555","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. The cryo-electron microscopy structure of huntingtin. Nature 555, 117\u2013120 (2018).","journal-title":"Nature"},{"key":"1159_CR31","doi-asserted-by":"publisher","first-page":"15916","DOI":"10.1074\/jbc.M511007200","volume":"281","author":"W Li","year":"2006","unstructured":"Li, W., Serpell, L. C., Carter, W. J., Rubinsztein, D. C. & Huntington, J. A. Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein. J. Biol. Chem. 281, 15916\u201315922 (2006).","journal-title":"J. Biol. Chem."},{"key":"1159_CR32","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1101\/gr.147400","volume":"10","author":"AF Neuwald","year":"2000","unstructured":"Neuwald, A. F. & Hirano, T. HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions. Genome Res. 10, 1445\u20131452 (2000).","journal-title":"Genome Res."},{"key":"1159_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031826","volume":"7","author":"MH Schaefer","year":"2012","unstructured":"Schaefer, M. H. et al. HIPPIE: integrating protein interaction networks with experiment based quality scores. PLoS ONE 7, e31826 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi, S. J., Flower, M. D., Ross, C. A. & Wild, E. J. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 16, 529\u2013546 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"1159_CR35","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel, K. B. et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J. Biol. Chem. 277, 7466\u20137476 (2002).","journal-title":"J. Biol. Chem."},{"key":"1159_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","volume":"19","author":"JP Caviston","year":"2009","unstructured":"Caviston, J. P. & Holzbaur, E. L. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol. 19, 147\u2013155 (2009).","journal-title":"Trends Cell Biol."},{"key":"1159_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071568","volume":"18","author":"S Koyuncu","year":"2017","unstructured":"Koyuncu, S., Fatima, A., Gutierrez-Garcia, R. & Vilchez, D. Proteostasis of huntingtin in health and disease. Int. J. Mol. Sci. 18, 1568 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes, P. & Wanker, E. E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28, 425\u2013433 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"1159_CR39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou, F. & Humbert, S. The biology of huntingtin. Neuron 89, 910\u2013926 (2016).","journal-title":"Neuron"},{"key":"1159_CR40","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","volume":"22","author":"J Gafni","year":"2002","unstructured":"Gafni, J. & Ellerby, L. M. Calpain activation in Huntington\u2019s disease. J. Neurosci. 22, 4842\u20134849 (2002).","journal-title":"J. Neurosci."},{"key":"1159_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham, R. K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179\u20131191 (2006).","journal-title":"Cell"},{"key":"1159_CR42","doi-asserted-by":"publisher","first-page":"12784","DOI":"10.1073\/pnas.221451398","volume":"98","author":"YJ Kim","year":"2001","unstructured":"Kim, Y. J. et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington\u2019s disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl Acad. Sci. USA 98, 12784\u201312789 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR43","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam, K. et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl Acad. Sci. USA 110, 2366\u20132370 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01510-z","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder, A. et al. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci. Rep. 7, 1307 (2017).","journal-title":"Sci. Rep."},{"key":"1159_CR45","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/jnr.24493","volume":"97","author":"NR Franich","year":"2019","unstructured":"Franich, N. R. et al. Phenotype onset in Huntington\u2019s disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene. J. Neurosci. Res. 97, 1590\u20131605 (2019).","journal-title":"J. Neurosci. Res."},{"key":"1159_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae410","volume":"6","author":"C Landles","year":"2024","unstructured":"Landles, C. et al. Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays. Brain Commun. 6, fcae410 (2024).","journal-title":"Brain Commun."},{"key":"1159_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jmg.30.12.982","volume":"30","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease. J. Med. Genet. 30, 982\u2013986 (1993).","journal-title":"J. Med. Genet."},{"key":"1159_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius, H. et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet. 6, 409\u2013414 (1994).","journal-title":"Nat. Genet."},{"key":"1159_CR49","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/hmg\/ddaa139","volume":"29","author":"R Mouro Pinto","year":"2020","unstructured":"Mouro Pinto, R. et al. Patterns of CAG repeat instability in the central nervous system and periphery in Huntington\u2019s disease and in spinocerebellar ataxia type 1. Hum. Mol. Genet. 29, 2551\u20132567 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat. Genet. 15, 197\u2013200 (1997).","journal-title":"Nat. Genet."},{"key":"1159_CR51","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/9.17.2539","volume":"9","author":"L Kennedy","year":"2000","unstructured":"Kennedy, L. & Shelbourne, P. F. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington\u2019s disease? Hum. Mol. Genet. 9, 2539\u20132544 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR52","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1073\/pnas.0800048105","volume":"105","author":"R Gonitel","year":"2008","unstructured":"Gonitel, R. et al. DNA instability in postmitotic neurons. Proc. Natl Acad. Sci. USA 105, 3467\u20133472 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410270403","volume":"27","author":"RL Albin","year":"1990","unstructured":"Albin, R. L., Reiner, A., Anderson, K. D., Penney, J. B. & Young, A. B. Striatal and nigral neuron subpopulations in rigid Huntington\u2019s disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27, 357\u2013365 (1990).","journal-title":"Ann. Neurol."},{"key":"1159_CR54","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner, A. et al. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl Acad. Sci. USA 85, 5733\u20135737 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin, R. L., Young, A. B. & Penney, J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366\u2013375 (1989).","journal-title":"Trends Neurosci."},{"key":"1159_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JHD-200429","volume":"10","author":"DG Monckton","year":"2021","unstructured":"Monckton, D. G. The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: a historical perspective. J. Huntingtons Dis. 10, 7\u201333 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn, D. R. et al. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin. Genet. 65, 267\u2013277 (2004).","journal-title":"Clin. Genet."},{"key":"1159_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JHD-200426","volume":"10","author":"VC Wheeler","year":"2021","unstructured":"Wheeler, V. C. & Dion, V. Modifiers of CAG\/CTG repeat instability: insights from mammalian models. J. Huntingtons Dis. 10, 123\u2013148 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JHD-200445","volume":"10","author":"J Donaldson","year":"2021","unstructured":"Donaldson, J. et al. What is the pathogenic CAG expansion length in Huntington\u2019s disease? J. Huntingtons Dis. 10, 175\u2013202 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JHD-200427","volume":"10","author":"EP Hong","year":"2021","unstructured":"Hong, E. P. et al. Huntington\u2019s disease pathogenesis: two sequential components. J. Huntingtons Dis. 10, 35\u201351 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR61","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee, J. M. et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78, 690\u2013695 (2012).","journal-title":"Neurology"},{"key":"1159_CR62","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/brain\/awg077","volume":"126","author":"F Squitieri","year":"2003","unstructured":"Squitieri, F. et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126, 946\u2013955 (2003).","journal-title":"Brain"},{"key":"1159_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/326194a0","volume":"326","author":"NS Wexler","year":"1987","unstructured":"Wexler, N. S. et al. Homozygotes for Huntington\u2019s disease. Nature 326, 194\u2013197 (1987).","journal-title":"Nature"},{"key":"1159_CR64","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/brain\/awae063","volume":"147","author":"SG Aldous","year":"2024","unstructured":"Aldous, S. G. et al. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington\u2019s disease. Brain 147, 1784\u20131798 (2024).","journal-title":"Brain"},{"key":"1159_CR65","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.cell.2025.01.031","volume":"188","author":"N Wang","year":"2025","unstructured":"Wang, N. et al. Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice. Cell 188,\u00a01524\u20131544\u00a0(2025).","journal-title":"Cell"},{"key":"1159_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/gm80","volume":"1","author":"JF Gusella","year":"2009","unstructured":"Gusella, J. F. & MacDonald, M. E. Huntington\u2019s disease: the case for genetic modifiers. Genome Med. 1, 80 (2009).","journal-title":"Genome Med."},{"key":"1159_CR67","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler, N. S. & The U.S.\u2013Venezuela Collaborative Research Project Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc. Natl Acad. Sci. USA 101, 3498\u20133503 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR68","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mds.26001","volume":"29","author":"JF Gusella","year":"2014","unstructured":"Gusella, J. F., MacDonald, M. E. & Lee, J.-M. Genetic modifiers of Huntington\u2019s disease. Mov. Disord. 29, 1359\u20131365 (2014).","journal-title":"Mov. Disord."},{"key":"1159_CR69","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581\u2013594 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1159_CR70","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","volume":"16","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Identification of genetic variants associated with Huntington\u2019s disease progression: a genome-wide association study. Lancet Neurol. 16, 701\u2013711 (2017).","journal-title":"Lancet Neurol."},{"key":"1159_CR71","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41593-022-01033-5","volume":"25","author":"B McAllister","year":"2022","unstructured":"McAllister, B. et al. Exome sequencing of individuals with Huntington\u2019s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. Nat. Neurosci. 25, 446\u2013457 (2022).","journal-title":"Nat. Neurosci."},{"key":"1159_CR72","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ebiom.2019.09.020","volume":"48","author":"M Ciosi","year":"2019","unstructured":"Ciosi, M. et al. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine 48, 568\u2013580 (2019).","journal-title":"EBioMedicine"},{"key":"1159_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","volume":"33","author":"E Dragileva","year":"2009","unstructured":"Dragileva, E. et al. Intergenerational and striatal CAG repeat instability in Huntington\u2019s disease knock-in mice involve different DNA repair genes. Neurobiol. Dis. 33, 37\u201347 (2009).","journal-title":"Neurobiol. Dis."},{"key":"1159_CR74","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/70598","volume":"23","author":"K Manley","year":"1999","unstructured":"Manley, K., Shirley, T. L., Flaherty, L. & Messer, A. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat. Genet. 23, 471\u2013473 (1999).","journal-title":"Nat. Genet."},{"key":"1159_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003930","volume":"9","author":"RM Pinto","year":"2013","unstructured":"Pinto, R. M. et al. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet. 9, e1003930 (2013).","journal-title":"PLoS Genet."},{"key":"1159_CR76","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/hmg\/ddg056","volume":"12","author":"VC Wheeler","year":"2003","unstructured":"Wheeler, V. C. et al. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. Hum. Mol. Genet. 12, 273\u2013281 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn4600","volume":"17","author":"EL Bunting","year":"2025","unstructured":"Bunting, E. L. et al. Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington\u2019s disease iPSC-derived striatal neurons. Sci. Transl. Med. 17, eadn4600 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1159_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109649","volume":"36","author":"R Goold","year":"2021","unstructured":"Goold, R. et al. FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington\u2019s disease. Cell Rep. 36, 109649 (2021).","journal-title":"Cell Rep."},{"key":"1159_CR79","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1093\/hmg\/ddaa196","volume":"29","author":"JM Loupe","year":"2020","unstructured":"Loupe, J. M. et al. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington\u2019s disease knock-in mice is blocked by Mlh1 knock-out. Hum. Mol. Genet. 29, 3044\u20133053 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47485-0","volume":"15","author":"ZL McLean","year":"2024","unstructured":"McLean, Z. L. et al. Splice modulators target PMS1 to reduce somatic expansion of the Huntington\u2019s disease-associated CAG repeat. Nat. Commun. 15, 3182 (2024).","journal-title":"Nat. Commun."},{"key":"1159_CR81","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41588-024-02054-5","volume":"57","author":"R Mouro Pinto","year":"2025","unstructured":"Mouro Pinto, R. et al. In vivo CRISPR\u2013Cas9 genome editing in mice identifies genetic modifiers of somatic CAG repeat instability in Huntington\u2019s disease. Nat. Genet. 57, 314\u2013322 (2025).","journal-title":"Nat. Genet."},{"key":"1159_CR82","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.ymthe.2023.05.006","volume":"31","author":"D O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly, D. et al. Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington\u2019s disease. Mol. Ther. 31, 1661\u20131674 (2023).","journal-title":"Mol. Ther."},{"key":"1159_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003280","volume":"9","author":"S Tom\u00e9","year":"2013","unstructured":"Tom\u00e9, S. et al. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington\u2019s disease mice. PLoS Genet. 9, e1003280 (2013).","journal-title":"PLoS Genet."},{"key":"1159_CR84","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajhg.2024.04.015","volume":"111","author":"R Ferguson","year":"2024","unstructured":"Ferguson, R., Goold, R., Coupland, L., Flower, M. & Tabrizi, S. J. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease. Am. J. Hum. Genet. 111, 1165\u20131183 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"1159_CR85","doi-asserted-by":"crossref","unstructured":"Howes, T. R. L. & Tomkinson, A. E. in The Eukaryotic Replisome: A Guide to Protein Structure and Function (ed. MacNeill, S.) 327\u2013341 (Springer, 2012).","DOI":"10.1007\/978-94-007-4572-8_17"},{"key":"1159_CR86","doi-asserted-by":"publisher","first-page":"26631","DOI":"10.1074\/jbc.M109.034405","volume":"284","author":"A L\u00f3pez Castel","year":"2009","unstructured":"L\u00f3pez Castel, A., Tomkinson, A. E. & Pearson, C. E. CTG\/CAG repeat instability is modulated by the levels of human DNA ligase I and its interaction with proliferating cell nuclear antigen: a distinction between replication and slipped-DNA repair. J. Biol. Chem. 284, 26631\u201326645 (2009).","journal-title":"J. Biol. Chem."},{"key":"1159_CR87","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2018.12.004","volume":"74","author":"I Gazy","year":"2019","unstructured":"Gazy, I., Hayward, B., Potapova, S., Zhao, X. & Usdin, K. Double-strand break repair plays a role in repeat instability in a Fragile X mouse model. DNA Repair 74, 63\u201369 (2019).","journal-title":"DNA Repair"},{"key":"1159_CR88","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae418","volume":"7","author":"KL Namuli","year":"2025","unstructured":"Namuli, K. L., Slike, A. N., Hollebeke, M. A. & Wright, G. E. B. Genomic characterization of Huntington\u2019s disease genetic modifiers informs drug target tractability. Brain Commun. 7, fcae418 (2025).","journal-title":"Brain Commun."},{"key":"1159_CR89","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2010.06.022","volume":"142","author":"K Kratz","year":"2010","unstructured":"Kratz, K. et al. Deficiency of FANCD2-associated nuclease KIAA1018\/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 142, 77\u201388 (2010).","journal-title":"Cell"},{"key":"1159_CR90","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.1192656","volume":"329","author":"T Liu","year":"2010","unstructured":"Liu, T., Ghosal, G., Yuan, J., Chen, J. & Huang, J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 329, 693\u2013696 (2010).","journal-title":"Science"},{"key":"1159_CR91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cell.2010.06.021","volume":"142","author":"C MacKay","year":"2010","unstructured":"MacKay, C. et al. Identification of KIAA1018\/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 142, 65\u201376 (2010).","journal-title":"Cell"},{"key":"1159_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molcel.2010.06.023","volume":"39","author":"A Smogorzewska","year":"2010","unstructured":"Smogorzewska, A. et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 39, 36\u201347 (2010).","journal-title":"Mol. Cell"},{"key":"1159_CR93","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","volume":"107","author":"K-H Kim","year":"2020","unstructured":"Kim, K.-H. et al. Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. Am. J. Hum. Genet. 107, 96\u2013110 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"1159_CR94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322924121","volume":"121","author":"K-H Kim","year":"2024","unstructured":"Kim, K.-H. et al. Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington\u2019s disease. Proc. Natl Acad. Sci. USA 121, e2322924121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR95","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1038\/s41467-025-59323-y","volume":"16","author":"F Li","year":"2025","unstructured":"Li, F. et al. Structural and molecular basis of PCNA-activated FAN1 nuclease function in DNA repair. Nat. Commun. 16, 4411 (2025).","journal-title":"Nat. Commun."},{"key":"1159_CR96","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/hmg\/ddy375","volume":"28","author":"R Goold","year":"2019","unstructured":"Goold, R. et al. FAN1 modifies Huntington\u2019s disease progression by stabilising the expanded HTT CAG repeat. Hum. Mol. Genet. 28, 650\u2013661 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR97","doi-asserted-by":"publisher","unstructured":"Cheng, Y.-C. et al. Increased FAN1 expression by mRNA-LNP attenuates CAG repeat expansion in Huntington patients\u2019 iPSC-derived astrocytes. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.11.24.568451 (2023).","DOI":"10.1101\/2023.11.24.568451"},{"key":"1159_CR98","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1016\/j.cell.2023.09.008","volume":"186","author":"T Gall-Duncan","year":"2023","unstructured":"Gall-Duncan, T. et al. Antagonistic roles of canonical and alternative-RPA in disease-associated tandem CAG repeat instability. Cell 186, 4898\u20134919 (2023).","journal-title":"Cell"},{"key":"1159_CR99","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajhg.2022.03.004","volume":"109","author":"JM Lee","year":"2022","unstructured":"Lee, J. M. et al. Genetic modifiers of Huntington disease differentially influence motor and cognitive domains. Am. J. Hum. Genet. 109, 885\u2013899 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1159_CR100","doi-asserted-by":"crossref","unstructured":"Clarke, C. & Lemon, R. in Neurology: A Queen Square Textbook (eds Clarke, C. et al.) 13\u201373 (Blackwell, 2009).","DOI":"10.1002\/9781444311709.ch2"},{"key":"1159_CR101","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi, S. J. et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 8, 791\u2013801 (2009).","journal-title":"Lancet Neurol."},{"key":"1159_CR102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 10, 31\u201342 (2011).","journal-title":"Lancet Neurol."},{"key":"1159_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-022-00317-w","volume":"7","author":"SV Lobanov","year":"2022","unstructured":"Lobanov, S. V. et al. Huntington\u2019s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1. NPJ Genom. Med. 7, 53 (2022).","journal-title":"NPJ Genom. Med."},{"key":"1159_CR104","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.232728","volume":"132","author":"C Moreno-Castro","year":"2019","unstructured":"Moreno-Castro, C., Prieto-S\u00e1nchez, S., S\u00e1nchez-Hern\u00e1ndez, N., Hern\u00e1ndez-Munain, C. & Su\u00f1\u00e9, C. Role for the splicing factor TCERG1 in Cajal body integrity and snRNP assembly. J. Cell Sci. 132, jcs232728 (2019).","journal-title":"J. Cell Sci."},{"key":"1159_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051894","volume":"21","author":"JEG Gallagher","year":"2020","unstructured":"Gallagher, J. E. G., Ser, S. L., Ayers, M. C., Nassif, C. & Pupo, A. The polymorphic polyQ tail protein of the mediator complex, Med15, regulates the variable response to diverse stresses. Int. J. Mol. Sci. 21, 1894 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-021-01178-y","volume":"19","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Formation of nuclear condensates by the Mediator complex subunit Med15 in mammalian cells. BMC Biol. 19, 245 (2021).","journal-title":"BMC Biol."},{"key":"1159_CR107","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","volume":"98","author":"S Holbert","year":"2001","unstructured":"Holbert, S. et al. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington\u2019s disease pathogenesis. Proc. Natl Acad. Sci. USA 98, 1811\u20131816 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR108","doi-asserted-by":"publisher","unstructured":"Ratovitski, T. et al. Huntingtin interactome reveals huntingtin role in regulation of double strand break DNA damage response (DSB\/DDR), chromatin remodeling and RNA processing pathways. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.12.27.630542 (2024).","DOI":"10.1101\/2024.12.27.630542"},{"key":"1159_CR109","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/ahg.12460","volume":"86","author":"A Yahia","year":"2022","unstructured":"Yahia, A. et al. Genetic diagnosis in Sudanese and Tunisian families with syndromic intellectual disability through exome sequencing. Ann. Hum. Genet. 86, 181\u2013194 (2022).","journal-title":"Ann. Hum. Genet."},{"key":"1159_CR110","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/cge.14135","volume":"102","author":"G Bauer","year":"2022","unstructured":"Bauer, G., Buchert, R., Haack, T. B., Harting, I. & Gutschalk, A. CCDC82 frameshift mutation associated with intellectual disability, spastic paraparesis, and dysmorphic features. Clin. Genet. 102, 80\u201381 (2022).","journal-title":"Clin. Genet."},{"key":"1159_CR111","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ng2040","volume":"39","author":"A Bourdon","year":"2007","unstructured":"Bourdon, A. et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 39, 776\u2013780 (2007).","journal-title":"Nat. Genet."},{"key":"1159_CR112","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/hmg\/2.10.1713","volume":"2","author":"DC Rubinsztein","year":"1993","unstructured":"Rubinsztein, D. C., Barton, D. E., Davison, B. C. C. & Ferguson-Smith, M. A. Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington\u2019s disease and CAG repeat number. Hum. Mol. Genet. 2, 1713\u20131715 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2022.100130","volume":"3","author":"J Dawson","year":"2022","unstructured":"Dawson, J. et al. A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry. Hum. Genet. Genom. Adv. 3, 100130 (2022).","journal-title":"Hum. Genet. Genom. Adv."},{"key":"1159_CR114","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/hmg\/3.1.65","volume":"3","author":"SE Andrew","year":"1994","unstructured":"Andrew, S. E., Goldberg, Y. P., Theilmann, J., Zeisler, J. & Hayden, M. R. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum. Mol. Genet. 3, 65\u201367 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000093867","volume":"55","author":"PK Panegyres","year":"2006","unstructured":"Panegyres, P. K., Beilby, J., Bulsara, M., Toufexis, K. & Wong, C. A study of potential interactive genetic factors in Huntington\u2019s disease. Eur. Neurol. 55, 189\u2013192 (2006).","journal-title":"Eur. Neurol."},{"key":"1159_CR116","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","volume":"104","author":"GEB Wright","year":"2019","unstructured":"Wright, G. E. B. et al. Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am. J. Hum. Genet. 104, 1116\u20131126 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"1159_CR117","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41436-020-0917-z","volume":"22","author":"H Findlay Black","year":"2020","unstructured":"Findlay Black, H. et al. Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range. Genet. Med. 22, 2108\u20132113 (2020).","journal-title":"Genet. Med."},{"key":"1159_CR118","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/hmg\/6.7.1117","volume":"6","author":"CE Pearson","year":"1997","unstructured":"Pearson, C. E., Ewel, A., Acharya, S., Fishel, R. A. & Sinden, R. R. Human MSH2 Binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases. Hum. Mol. Genet. 6, 1117\u20131123 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR119","unstructured":"Gomes-Pereira, M., Bidichandani, S. I. & Monckton, D. G. in Trinucleotide Repeat Protocols (ed. Kohwi, Y.) 61\u201376 (Humana, 2004)."},{"key":"1159_CR120","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cell.2019.08.055","volume":"179","author":"T Garc\u00eda-Muse","year":"2019","unstructured":"Garc\u00eda-Muse, T. & Aguilera, A. R loops: from physiological to pathological roles. Cell 179, 604\u2013618 (2019).","journal-title":"Cell"},{"key":"1159_CR121","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1126\/science.7604264","volume":"268","author":"JT Drummond","year":"1995","unstructured":"Drummond, J. T., Li, G.-M., Longley, M. J. & Modrich, P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268, 1909\u20131912 (1995).","journal-title":"Science"},{"key":"1159_CR122","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.7604265","volume":"268","author":"F Palombo","year":"1995","unstructured":"Palombo, F. et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268, 1912\u20131914 (1995).","journal-title":"Science"},{"key":"1159_CR123","doi-asserted-by":"publisher","first-page":"13629","DOI":"10.1073\/pnas.93.24.13629","volume":"93","author":"S Acharya","year":"1996","unstructured":"Acharya, S. et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl Acad. Sci. USA 93, 13629\u201313634 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR124","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0960-9822(02)70685-4","volume":"6","author":"F Palombo","year":"1996","unstructured":"Palombo, F. et al. hMutS\u03b2, a heterodimer of hMSH2 and hMSH3, binds to insertion\/deletion loops in DNA. Curr. Biol. 6, 1181\u20131184 (1996).","journal-title":"Curr. Biol."},{"key":"1159_CR125","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.molcel.2007.04.018","volume":"26","author":"JJ Warren","year":"2007","unstructured":"Warren, J. J. et al. Structure of the human MutS\u03b1 DNA lesion recognition complex. Mol. Cell 26, 579\u2013592 (2007).","journal-title":"Mol. Cell"},{"key":"1159_CR126","doi-asserted-by":"publisher","first-page":"14822","DOI":"10.1073\/pnas.2433654100","volume":"100","author":"H Wang","year":"2003","unstructured":"Wang, H. et al. DNA bending and unbending by MutS govern mismatch recognition and specificity. Proc. Natl Acad. Sci. USA 100, 14822\u201314827 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR127","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cell.2006.05.039","volume":"126","author":"FA Kadyrov","year":"2006","unstructured":"Kadyrov, F. A., Dzantiev, L., Constantin, N. & Modrich, P. Endonucleolytic function of MutL\u03b1 in human mismatch repair. Cell 126, 297\u2013308 (2006).","journal-title":"Cell"},{"key":"1159_CR128","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1073\/pnas.1914718117","volume":"117","author":"LY Kadyrova","year":"2020","unstructured":"Kadyrova, L. Y., Gujar, V., Burdett, V., Modrich, P. L. & Kadyrov, F. A. Human MutL\u03b3, the MLH1\u2013MLH3 heterodimer, is an endonuclease that promotes DNA expansion. Proc. Natl Acad. Sci. USA 117, 3535\u20133542 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR129","doi-asserted-by":"publisher","first-page":"11730","DOI":"10.1074\/jbc.M110.104125","volume":"285","author":"RR Iyer","year":"2010","unstructured":"Iyer, R. R. et al. MutL\u03b1 and proliferating cell nuclear antigen share binding sites on MutS\u03b2. J. Biol. Chem. 285, 11730\u201311739 (2010).","journal-title":"J. Biol. Chem."},{"key":"1159_CR130","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1073\/pnas.1702561114","volume":"114","author":"J Genschel","year":"2017","unstructured":"Genschel, J. et al. Interaction of proliferating cell nuclear antigen with PMS2 is required for MutL\u03b1 activation and function in mismatch repair. Proc. Natl Acad. Sci. USA 114, 4930\u20134935 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR131","doi-asserted-by":"publisher","first-page":"16066","DOI":"10.1073\/pnas.1010662107","volume":"107","author":"A Pluciennik","year":"2010","unstructured":"Pluciennik, A. et al. PCNA function in the activation and strand direction of MutL\u03b1 endonuclease in mismatch repair. Proc. Natl Acad. Sci. USA 107, 16066\u201316071 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR132","doi-asserted-by":"publisher","first-page":"12277","DOI":"10.1073\/pnas.1311325110","volume":"110","author":"A Pluciennik","year":"2013","unstructured":"Pluciennik, A. et al. Extrahelical (CAG)\/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutL\u03b1 endonuclease activation. Proc. Natl Acad. Sci. USA 110, 12277\u201312282 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR133","doi-asserted-by":"publisher","unstructured":"Jimenez, D. A. et al. PMS2 has both pro-mutagenic and anti-mutagenic effects on repeat instability in the repeat expansion diseases. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.13.607839 (2025).","DOI":"10.1101\/2024.08.13.607839"},{"key":"1159_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007719","volume":"14","author":"X Zhao","year":"2018","unstructured":"Zhao, X., Zhang, Y., Wilkins, K., Edelmann, W. & Usdin, K. MutL\u03b3 promotes repeat expansion in a Fragile X mouse model while EXO1 is protective. PLoS Genet. 14, e1007719 (2018).","journal-title":"PLoS Genet."},{"key":"1159_CR135","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1073\/pnas.0903654106","volume":"106","author":"FA Kadyrov","year":"2009","unstructured":"Kadyrov, F. A. et al. A possible mechanism for exonuclease 1-independent eukaryotic mismatch repair. Proc. Natl Acad. Sci. USA 106, 8495\u20138500 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR136","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1074\/jbc.M609989200","volume":"282","author":"E Cannavo","year":"2007","unstructured":"Cannavo, E., Gerrits, B., Marra, G., Schlapbach, R. & Jiricny, J. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J. Biol. Chem. 282, 2976\u20132986 (2007).","journal-title":"J. Biol. Chem."},{"key":"1159_CR137","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf7906","volume":"7","author":"A Porro","year":"2021","unstructured":"Porro, A. et al. FAN1-MLH1 interaction affects repair of DNA interstrand cross-links and slipped-CAG\/CTG repeats. Sci. Adv. 7, eabf7906 (2021).","journal-title":"Sci. Adv."},{"key":"1159_CR138","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nsmb.1638","volume":"16","author":"C Hou","year":"2009","unstructured":"Hou, C., Chan, N. L. S., Gu, L. & Li, G.-M. Incision-dependent and error-free repair of (CAG)n\/(CTG)n hairpins in human cell extracts. Nat. Struct. Mol. Biol. 16, 869\u2013875 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1159_CR139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302103120","volume":"120","author":"AS Phadte","year":"2023","unstructured":"Phadte, A. S. et al. FAN1 removes triplet repeat extrusions via a PCNA- and RFC-dependent mechanism. Proc. Natl Acad. Sci. USA 120, e2302103120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64480-z","volume":"14","author":"B Hayward","year":"2024","unstructured":"Hayward, B. et al. All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency. Sci. Rep. 14, 13772 (2024).","journal-title":"Sci. Rep."},{"key":"1159_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008902","volume":"16","author":"CJ Miller","year":"2020","unstructured":"Miller, C. J., Kim, G.-Y., Zhao, X. & Usdin, K. All three mammalian MutL complexes are required for repeat expansion in a mouse cell model of the Fragile X-related disorders. PLoS Genet. 16, e1008902 (2020).","journal-title":"PLoS Genet."},{"key":"1159_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046807","volume":"7","author":"Y Lin","year":"2012","unstructured":"Lin, Y. & Wilson, J. H. Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability. PLoS ONE 7, e46807 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101144","volume":"297","author":"KY Chan","year":"2021","unstructured":"Chan, K. Y., Li, X., Ortega, J., Gu, L. & Li, G.-M. DNA polymerase \u03b8 promotes CAG\u00b7CTG repeat expansions in Huntington\u2019s disease via insertion sequences of its catalytic domain. J. Biol. Chem. 297, 101144 (2021).","journal-title":"J. Biol. Chem."},{"key":"1159_CR144","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun, I. V. et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447, 447\u2013452 (2007).","journal-title":"Nature"},{"key":"1159_CR145","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1093\/hmg\/dds337","volume":"21","author":"L M\u00f8llersen","year":"2012","unstructured":"M\u00f8llersen, L. et al. Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6\/1 mice. Hum. Mol. Genet. 21, 4939\u20134947 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005267","volume":"11","author":"H Budworth","year":"2015","unstructured":"Budworth, H. et al. Suppression of somatic expansion delays the onset of pathophysiology in a mouse model of Huntington\u2019s disease. PLoS Genet. 11, e1005267 (2015).","journal-title":"PLoS Genet."},{"key":"1159_CR147","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.scr.2013.08.010","volume":"11","author":"I Jonson","year":"2013","unstructured":"Jonson, I., Ougland, R., Klungland, A. & Larsen, E. Oxidative stress causes DNA triplet expansion in Huntington\u2019s disease mouse embryonic stem cells. Stem Cell Res. 11, 1264\u20131271 (2013).","journal-title":"Stem Cell Res."},{"key":"1159_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.606331","volume":"14","author":"M Gomes-Pereira","year":"2020","unstructured":"Gomes-Pereira, M. & Monckton, D. G. Chronic exposure to cadmium and antioxidants does not affect the dynamics of expanded CAG*CTG trinucleotide repeats in a mouse cell culture system of unstable DNA. Front. Cell. Neurosci. 14, 606331 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"1159_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001242","volume":"6","author":"L M\u00f8llersen","year":"2010","unstructured":"M\u00f8llersen, L., Rowe, A. D., Larsen, E., Rognes, T. & Klungland, A. Continuous and periodic expansion of CAG repeats in Huntington\u2019s disease R6\/1 mice. PLoS Genet. 6, e1001242 (2010).","journal-title":"PLoS Genet."},{"key":"1159_CR150","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/hmg\/dds059","volume":"21","author":"CF Higham","year":"2012","unstructured":"Higham, C. F., Morales, F., Cobbold, C. A., Haydon, D. T. & Monckton, D. G. High levels of somatic DNA diversity at the myotonic dystrophy type 1 locus are driven by ultra-frequent expansion and contraction mutations. Hum. Mol. Genet. 21, 2450\u20132463 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR151","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-200423","volume":"10","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. Modifiers of somatic repeat instability in mouse models of Friedreich ataxia and the Fragile X-related disorders: implications for the mechanism of somatic expansion in Huntington\u2019s disease. J. Huntingtons Dis. 10, 149\u2013163 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR152","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ana.24656","volume":"79","author":"C Bettencourt","year":"2016","unstructured":"Bettencourt, C. et al. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Ann. Neurol. 79, 983\u2013990 (2016).","journal-title":"Ann. Neurol."},{"key":"1159_CR153","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.dnarep.2016.01.001","volume":"40","author":"F Morales","year":"2016","unstructured":"Morales, F. et al. A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. DNA Repair 40, 57\u201366 (2016).","journal-title":"DNA Repair"},{"key":"1159_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14183-0","volume":"12","author":"YH Hwang","year":"2022","unstructured":"Hwang, Y. H. et al. Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation. Sci. Rep. 12, 10419 (2022).","journal-title":"Sci. Rep."},{"key":"1159_CR155","doi-asserted-by":"publisher","unstructured":"Hujoel, M. L. A. et al. Insights into the causes and consequences of DNA repeat expansions from 700,000 biobank participants. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.25.625248 (2024).","DOI":"10.1101\/2024.11.25.625248"},{"key":"1159_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23491-4","volume":"12","author":"B-H Laabs","year":"2021","unstructured":"Laabs, B.-H. et al. Identifying genetic modifiers of age-associated penetrance in X-linked dystonia-parkinsonism. Nat. Commun. 12, 3216 (2021).","journal-title":"Nat. Commun."},{"key":"1159_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044273","volume":"7","author":"M Kovalenko","year":"2012","unstructured":"Kovalenko, M. et al. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington\u2019s disease knock-in mice. PLoS ONE 7, e44273 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR158","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.dnarep.2018.02.007","volume":"64","author":"T Rao","year":"2018","unstructured":"Rao, T. et al. Importance of homo-dimerization of Fanconi-associated nuclease 1 in DNA flap cleavage. DNA Repair 64, 53\u201358 (2018).","journal-title":"DNA Repair"},{"key":"1159_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000482","volume":"5","author":"S Tom\u00e9","year":"2009","unstructured":"Tom\u00e9, S. et al. MSH2 ATPase domain mutation affects CTG\u00b7CAG repeat instability in transgenic mice. PLoS Genet. 5, e1000482 (2009).","journal-title":"PLoS Genet."},{"key":"1159_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/humu.22464","volume":"35","author":"RA Lokanga","year":"2014","unstructured":"Lokanga, R. A., Zhao, X.-N. & Usdin, K. The mismatch repair protein MSH2 is rate limiting for repeat expansion in a Fragile X premutation mouse model. Hum. Mutat. 35, 129\u2013136 (2014).","journal-title":"Hum. Mutat."},{"key":"1159_CR161","first-page":"7087","volume":"24","author":"XN Zhao","year":"2015","unstructured":"Zhao, X. N. et al. Muts\u03b2 generates both expansions and contractions in a mouse model of the Fragile X-associated disorders. Hum. Mol. Genet. 24, 7087\u20137096 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR162","doi-asserted-by":"publisher","first-page":"11643","DOI":"10.1093\/nar\/gkab899","volume":"49","author":"X Zhao","year":"2021","unstructured":"Zhao, X., Lu, H. & Usdin, K. FAN1\u2019s protection against CGG repeat expansion requires its nuclease activity and is FANCD2-independent. Nucleic Acids Res. 49, 11643\u201311652 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2018.07.001","volume":"69","author":"X-N Zhao","year":"2018","unstructured":"Zhao, X.-N. & Usdin, K. FAN1 protects against repeat expansions in a Fragile X mouse model. DNA Repair 69, 1\u20135 (2018).","journal-title":"DNA Repair"},{"key":"1159_CR164","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00439-006-0164-7","volume":"119","author":"L Foiry","year":"2006","unstructured":"Foiry, L. et al. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Hum. Genet. 119, 520\u2013526 (2006).","journal-title":"Hum. Genet."},{"key":"1159_CR165","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/hmg\/11.2.191","volume":"11","author":"W van den Broek","year":"2002","unstructured":"van den Broek, W. et al. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum. Mol. Genet. 11, 191\u2013198 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6726","volume":"5","author":"Q Zhao","year":"2014","unstructured":"Zhao, Q., Xue, X., Longerich, S., Sung, P. & Xiong, Y. Structural insights into 5\u2032 flap DNA unwinding and incision by the human FAN1 dimer. Nat. Commun. 5, 5726 (2014).","journal-title":"Nat. Commun."},{"key":"1159_CR167","doi-asserted-by":"publisher","first-page":"11557","DOI":"10.1074\/jbc.M900908200","volume":"284","author":"L Tian","year":"2009","unstructured":"Tian, L., Gu, L. & Li, G.-M. Distinct nucleotide binding\/hydrolysis properties and molar ratio of MutS\u03b1 and MutS\u03b2 determine their differential mismatch binding activities. J. Biol. Chem. 284, 11557\u201311562 (2009).","journal-title":"J. Biol. Chem."},{"key":"1159_CR168","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww087","volume":"139","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. (CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China. Brain 139, e41 (2016).","journal-title":"Brain"},{"key":"1159_CR169","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx122","volume":"140","author":"G Stuitje","year":"2017","unstructured":"Stuitje, G. et al. Age of onset in Huntington\u2019s disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes. Brain 140, e42 (2017).","journal-title":"Brain"},{"key":"1159_CR170","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awu174","volume":"137","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel, S. et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 137, 2444\u20132455 (2014).","journal-title":"Brain"},{"key":"1159_CR171","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/ene.13954","volume":"26","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. (CAG)n loci as genetic modifiers of age at onset in patients with spinocerebellar ataxia type 1 from mainland China. Eur. J. Neurol. 26, 1130\u20131136 (2019).","journal-title":"Eur. J. Neurol."},{"key":"1159_CR172","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae016","volume":"6","author":"EP Hong","year":"2024","unstructured":"Hong, E. P. et al. Modification of Huntington\u2019s disease by short tandem repeats. Brain Commun. 6, fcae016 (2024).","journal-title":"Brain Commun."},{"key":"1159_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang, A., Handley, R. R., Lehnert, K. & Snell, R. G. From pathogenesis to therapeutics: a review of 150 years of Huntington\u2019s disease research. Int. J. Mol. Sci. 24, 13021 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR174","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 21, 645\u2013658 (2022).","journal-title":"Lancet Neurol."},{"key":"1159_CR175","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1093\/nar\/gkae368","volume":"52","author":"J Belgrad","year":"2024","unstructured":"Belgrad, J. et al. A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic Acids Res. 52, 6099\u20136113 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR176","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","volume":"19","author":"RI Scahill","year":"2020","unstructured":"Scahill, R. I. et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington\u2019s Disease Young Adult Study (HD-YAS): a cross-sectional analysis. Lancet Neurol. 19, 502\u2013512 (2020).","journal-title":"Lancet Neurol."},{"key":"1159_CR177","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. A biological classification of Huntington\u2019s disease: the integrated staging system. Lancet Neurol. 21, 632\u2013644 (2022).","journal-title":"Lancet Neurol."},{"key":"1159_CR178","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41591-024-03424-6","volume":"31","author":"RI Scahill","year":"2025","unstructured":"Scahill, R. I. et al. Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington\u2019s disease decades before clinical motor diagnosis. Nat. Med. 31, 807\u2013818 (2025).","journal-title":"Nat. Med."},{"key":"1159_CR179","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"S Tabrizi","year":"2019","unstructured":"Tabrizi, S. et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR180","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMc2300400","volume":"389","author":"P McColgan","year":"2023","unstructured":"McColgan, P. et al. Tominersen in adults with manifest Huntington\u2019s disease. N. Engl. J. Med. 389, 2203\u20132205 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1159_CR181","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1093\/brain\/awac241","volume":"145","author":"S Fienko","year":"2022","unstructured":"Fienko, S. et al. Alternative processing of human HTT mRNA with implications for Huntington\u2019s disease therapeutics. Brain 145, 4409\u20134424 (2022).","journal-title":"Brain"},{"key":"1159_CR182","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac248","volume":"4","author":"S Ly","year":"2022","unstructured":"Ly, S. et al. Mutant huntingtin messenger RNA forms neuronal nuclear clusters in rodent and human brains. Brain Commun. 4, fcac248 (2022).","journal-title":"Brain Commun."},{"key":"1159_CR183","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/18796397241293955","volume":"13","author":"M Farag","year":"2024","unstructured":"Farag, M., Tabrizi, S. J. & Wild, E. J. Huntington\u2019s disease clinical trials update: September 2024. J. Huntingtons Dis. 13, 409\u2013418 (2024).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR184","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.aax3338","volume":"369","author":"M Barnat","year":"2020","unstructured":"Barnat, M. et al. Huntington\u2019s disease alters human neurodevelopment. Science 369, 787\u2013793 (2020).","journal-title":"Science"},{"key":"1159_CR185","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho, L. W., Brown, R., Maxwell, M., Wyttenbach, A. & Rubinsztein, D. C. Wild type huntingtin reduces the cellular toxicity of mutant huntingtin in mammalian cell models of Huntington\u2019s disease. J. Med. Genet. 38, 450 (2001).","journal-title":"J. Med. Genet."},{"key":"1159_CR186","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/MN:28:3:259","volume":"28","author":"A Reiner","year":"2003","unstructured":"Reiner, A., Dragatsis, I., Zeitlin, S. & Goldowitz, D. Wild-type huntingtin plays a role in brain development and neuronal survival. Mol. Neurobiol. 28, 259\u2013275 (2003).","journal-title":"Mol. Neurobiol."},{"key":"1159_CR187","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178\u20132185 (2011).","journal-title":"Mol. Ther."},{"key":"1159_CR188","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/mt.2015.128","volume":"23","author":"C Kay","year":"2015","unstructured":"Kay, C. et al. Huntingtin haplotypes provide prioritized target panels for allele-specific silencing in Huntington disease patients of European ancestry. Mol. Ther. 23, 1759\u20131771 (2015).","journal-title":"Mol. Ther."},{"key":"1159_CR189","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JHD-200421","volume":"10","author":"CL Benn","year":"2021","unstructured":"Benn, C. L., Gibson, K. R. & Reynolds, D. S. Drugging DNA damage repair pathways for trinucleotide repeat expansion diseases. J. Huntingtons Dis. 10, 203\u2013220 (2021).","journal-title":"J. Huntingtons Dis."},{"key":"1159_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186716","volume":"21","author":"M Caccese","year":"2020","unstructured":"Caccese, M. et al. Mismatch-repair protein expression in high-grade gliomas: a large retrospective multicenter study. Int. J. Mol. Sci. 21, 6716 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1159_CR191","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S1470-2045(24)00026-3","volume":"25","author":"AB Ercan","year":"2024","unstructured":"Ercan, A. B. et al. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study. Lancet Oncol. 25, 668\u2013682 (2024).","journal-title":"Lancet Oncol."},{"key":"1159_CR192","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"1159_CR193","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41416-022-02059-z","volume":"128","author":"AB Abildgaard","year":"2023","unstructured":"Abildgaard, A. B. et al. Lynch syndrome, molecular mechanisms and variant classification. Br. J. Cancer 128, 726\u2013734 (2023).","journal-title":"Br. J. Cancer"},{"key":"1159_CR194","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mam.2019.03.001","volume":"69","author":"L Valle","year":"2019","unstructured":"Valle, L. et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol. Asp. Med. 69, 10\u201326 (2019).","journal-title":"Mol. Asp. Med."},{"key":"1159_CR195","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.chembiol.2022.10.008","volume":"29","author":"B Ruprecht","year":"2022","unstructured":"Ruprecht, B. et al. Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteins. Cell Chem. Biol. 29, 1639\u20131648 (2022).","journal-title":"Cell Chem. Biol."},{"key":"1159_CR196","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1093\/nar\/gkx650","volume":"45","author":"N Keogh","year":"2017","unstructured":"Keogh, N., Chan, K. Y., Li, G.-M. & Lahue, R. S. MutS\u03b2 abundance and Msh3 ATP hydrolysis activity are important drivers of CTG\u00b7CAG repeat expansions. Nucleic Acids Res. 45, 10068\u201310078 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130326","volume":"128","author":"G Brace","year":"2025","unstructured":"Brace, G. et al. Orthosteric inhibition of MutS\u03b2 ATPase function: First disclosure of MSH3-bound small molecule inhibitors. Bioorg. Med. Chem. Lett. 128, 130326 (2025).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1159_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2022.103405","volume":"119","author":"ML DuPrie","year":"2022","unstructured":"DuPrie, M. L., Palacio, T., Calil, F. A., Kolodner, R. D. & Putnam, C. D. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair. DNA Repair 119, 103405 (2022).","journal-title":"DNA Repair"},{"key":"1159_CR199","doi-asserted-by":"publisher","first-page":"23597","DOI":"10.1073\/pnas.2013223117","volume":"117","author":"GM Williams","year":"2020","unstructured":"Williams, G. M. et al. HDAC3 deacetylates the DNA mismatch repair factor MutS\u03b2 to stimulate triplet repeat expansions. Proc. Natl Acad. Sci. USA 117, 23597\u201323605 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR200","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52667-3","volume":"14","author":"R Driscoll","year":"2024","unstructured":"Driscoll, R. et al. Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice. Sci. Rep. 14, 2061 (2024).","journal-title":"Sci. Rep."},{"key":"1159_CR201","doi-asserted-by":"crossref","first-page":"A142","DOI":"10.1136\/jnnp-2023-331920","volume":"95","author":"T Wager","year":"2024","unstructured":"Wager, T. Small molecule PMS1 regulators to treat repeat expansion diseases: Huntington\u2019s disease (HD) and beyond [abstract I002]. J. Neurol. Neurosurg. Psychiatry 95, A142 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1159_CR202","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.4161\/cbt.8.14.8886","volume":"8","author":"N Charbonneau","year":"2009","unstructured":"Charbonneau, N., Amunugama, R., Schmutte, C., Yoder, K. & Fishel, R. Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair. Cancer Biol. Ther. 8, 1411\u20131420 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"1159_CR203","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1158\/0008-5472.CAN-05-0742","volume":"65","author":"P-C Chen","year":"2005","unstructured":"Chen, P.-C. et al. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Cancer Res. 65, 8662\u20138670 (2005).","journal-title":"Cancer Res."},{"key":"1159_CR204","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ng931","volume":"31","author":"SM Lipkin","year":"2002","unstructured":"Lipkin, S. M. et al. Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat. Genet. 31, 385\u2013390 (2002).","journal-title":"Nat. Genet."},{"key":"1159_CR205","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022704118","volume":"118","author":"J Dai","year":"2021","unstructured":"Dai, J. et al. Molecular basis of the dual role of the Mlh1-Mlh3 endonuclease in MMR and in meiotic crossover formation. Proc. Natl Acad. Sci. USA 118, e2022704118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR206","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3878","volume":"15","author":"HT Lynch","year":"2015","unstructured":"Lynch, H. T., Snyder, C. L., Shaw, T. G., Heinen, C. D. & Hitchins, M. P. Milestones of Lynch syndrome: 1895\u20132015. Nat. Rev. Cancer 15, 181\u2013194 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1159_CR207","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1093\/nar\/gky143","volume":"46","author":"A Halabi","year":"2018","unstructured":"Halabi, A., Fuselier, K. T. B. & Grabczyk, E. GAA\u00b7TTC repeat expansion in human cells is mediated by mismatch repair complex MutL\u03b3 and depends upon the endonuclease domain in MLH3 isoform one. Nucleic Acids Res. 46, 4022\u20134032 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR208","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1093\/nar\/gkab152","volume":"49","author":"JCL Roy","year":"2021","unstructured":"Roy, J. C. L. et al. Somatic CAG expansion in Huntington\u2019s disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection. Nucleic Acids Res. 49, 3907\u20133918 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR209","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler, V. C. et al. Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum. Mol. Genet. 8, 115\u2013122 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR210","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens, M. A. & Hastings, M. L. Splice-switching antisense oligonucleotides as therapeutic drugs. Nucleic Acids Res. 44, 6549\u20136563 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107264","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Xue, H. & Jin, J. Applications of protein ubiquitylation and deubiquitylation in drug discovery. J. Biol. Chem. 300, 107264 (2024).","journal-title":"J. Biol. Chem."},{"key":"1159_CR212","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89782.2","volume":"12","author":"DE Choi","year":"2024","unstructured":"Choi, D. E. et al. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington\u2019s disease. eLife 12, RP89782 (2024).","journal-title":"eLife"},{"key":"1159_CR213","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41588-025-02172-8","volume":"57","author":"Z Matuszek","year":"2025","unstructured":"Matuszek, Z. et al. Base editing of trinucleotide repeats that cause Huntington\u2019s disease and Friedreich\u2019s ataxia reduces somatic repeat expansions in patient cells and in mice. Nat. Genet. 57, 1437\u20131451 (2025).","journal-title":"Nat. Genet."},{"key":"1159_CR214","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64674","volume":"10","author":"R Kacher","year":"2021","unstructured":"Kacher, R. et al. Propensity for somatic expansion increases over the course of life in Huntington disease. eLife 10, e64674 (2021).","journal-title":"eLife"},{"key":"1159_CR215","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00439-024-02698-7","volume":"143","author":"AM Sidky","year":"2024","unstructured":"Sidky, A. M. et al. Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal swab DNA of individuals with spinocerebellar ataxia type 3\/Machado-Joseph disease. Hum. Genet. 143, 1363\u20131378 (2024).","journal-title":"Hum. Genet."},{"key":"1159_CR216","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049453","volume":"15","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. Stool is a sensitive and noninvasive source of DNA for monitoring expansion in repeat expansion disease mouse models. Dis. Models Mech. 15, dmm049453 (2022).","journal-title":"Dis. Models Mech."},{"key":"1159_CR217","doi-asserted-by":"publisher","first-page":"8834","DOI":"10.1073\/pnas.1331390100","volume":"100","author":"S-R Yoon","year":"2003","unstructured":"Yoon, S.-R., Dubeau, L., de Young, M., Wexler, N. S. & Arnheim, N. Huntington disease expansion mutations in humans can occur before meiosis is completed. Proc. Natl Acad. Sci. USA 100, 8834\u20138838 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR218","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang, C. C. et al. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24, 217\u2013233 (1998).","journal-title":"Somat. Cell Mol. Genet."},{"key":"1159_CR219","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan, J. S. et al. The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA 97, 6763\u20136768 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR220","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato, C. et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76\u201383 (2003).","journal-title":"Nat. Genet."},{"key":"1159_CR221","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau, M. et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum. Mol. Genet. 19, 3053\u20133067 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR222","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00193","volume":"9","author":"HM Yang","year":"2017","unstructured":"Yang, H. M., Yang, S., Huang, S. S., Tang, B. S. & Guo, J. F. Microglial activation in the pathogenesis of Huntington\u2019s disease. Front. Aging Neurosci. 9, 193 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"1159_CR223","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","volume":"58","author":"MC Garrett","year":"1992","unstructured":"Garrett, M. C. & Soares-da-Silva, P. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: evidence for an overactive dopaminergic brain transmission. J. Neurochem. 58, 101\u2013106 (1992).","journal-title":"J. Neurochem."},{"key":"1159_CR224","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ana.410220318","volume":"22","author":"SJ Kish","year":"1987","unstructured":"Kish, S. J., Shannak, K. & Hornykiewicz, O. Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum. Ann. Neurol. 22, 386\u2013389 (1987).","journal-title":"Ann. Neurol."},{"key":"1159_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101239","volume":"26","author":"J Dawson","year":"2024","unstructured":"Dawson, J. et al. The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohort. Genet. Med. 26, 101239 (2024).","journal-title":"Genet. Med."},{"key":"1159_CR226","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.050930","volume":"44","author":"VC Wheeler","year":"2007","unstructured":"Wheeler, V. C. et al. Factors associated with HD CAG repeat instability in Huntington disease. J. Med. Genet. 44, 695\u2013701 (2007).","journal-title":"J. Med. Genet."},{"key":"1159_CR227","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/mds.24065","volume":"27","author":"EM Ramos","year":"2012","unstructured":"Ramos, E. M. et al. Intergenerational instability in Huntington disease: extreme repeat changes among 134 transmissions. Mov. Disord. 27, 583\u2013585 (2012).","journal-title":"Mov. Disord."},{"key":"1159_CR228","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","volume":"2","author":"H Telenius","year":"1993","unstructured":"Telenius, H. et al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum. Mol. Genet. 2, 1535\u20131540 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR229","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/ajmg.a.32901","volume":"149A","author":"AE Hendricks","year":"2009","unstructured":"Hendricks, A. E. et al. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27\u201335 CAG). Am. J. Med. Genet. A 149A, 1375\u20131381 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"1159_CR230","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ajmg.b.30970","volume":"153B","author":"A Semaka","year":"2010","unstructured":"Semaka, A., Collins, J. A. & Hayden, M. R. Unstable familial transmissions of Huntington disease alleles with 27\u201335 CAG repeats (intermediate alleles). Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 314\u2013320 (2010).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"1159_CR231","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","volume":"15","author":"A Lloret","year":"2006","unstructured":"Lloret, A. et al. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice. Hum. Mol. Genet. 15, 2015\u20132024 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"1159_CR232","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","volume":"21","author":"K Iba\u00f1ez","year":"2022","unstructured":"Iba\u00f1ez, K. et al. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study. Lancet Neurol. 21, 234\u2013245 (2022).","journal-title":"Lancet Neurol."},{"key":"1159_CR233","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz501","volume":"47","author":"N Mousavi","year":"2019","unstructured":"Mousavi, N., Shleizer-Burko, S., Yanicky, R. & Gymrek, M. Profiling the genome-wide landscape of tandem repeat expansions. Nucleic Acids Res. 47, e90 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1159_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06694-0","volume":"9","author":"S Saini","year":"2018","unstructured":"Saini, S., Mitra, I., Mousavi, N., Fotsing, S. F. & Gymrek, M. A reference haplotype panel for genome-wide imputation of short tandem repeats. Nat. Commun. 9, 4397 (2018).","journal-title":"Nat. Commun."},{"key":"1159_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39547-6","volume":"14","author":"S Kristmundsdottir","year":"2023","unstructured":"Kristmundsdottir, S. et al. Sequence variants affecting the genome-wide rate of germline microsatellite mutations. Nat. Commun. 14, 3855 (2023).","journal-title":"Nat. Commun."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01159-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01159-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01159-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:02:23Z","timestamp":1767618143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01159-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":235,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1038\/s41582-025-01159-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"3 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.T. reports research grant funding over the past 3\u2009years from the CHDI Foundation, the NIHR Clinical Research Network, UK Medical Research Council (MR\/X008029\/1), UK Dementia Research Institute (principally funded by the UK Medical Research Council), and the Wellcome Trust (223082\/Z\/21\/Z). S.J.T. also reports that over the past 3\u2009years consultancy fees for advisory services were paid to University College London Consultants, a wholly owned subsidiary of University College London from the following companies: Alchemab, Alnylam Pharmaceuticals, Annexon Bioscience, Arrowhead, Atalanta Therapeutics, Catapult, Design Therapeutics, EcoR1, F. Hoffman-La Roche, Harness Therapeutics, Ipsen, Iris Medicine, Latus Bio, LifeEdit, Novartis Pharma, Pfizer, Prilenia, Prime Global, PTC Therapeutics, Rgenta Therapeutics, SkyHawk, Takeda Pharmaceuticals, Triplet Therapeutics, UniQure Biopharma, Vertex Pharmaceuticals, Vico Therapeutics, and Wave Life Sciences. S.J.T. has also consulted for Abingworth, Andera Partners, Ascidian Therapeutics, EQT, Cure Ventures, FunctionRX, Harrisson & Star, IQVIA and LifeLink through the office of Celtic Phenomenon. In the past 3\u2009years, in University College London Hospitals NHS Foundation Trust\u00a0host clinical institution S.J.T. has received funding to run clinical trials for Alnylam Pharmaceuticals, F. Hoffman-La Roche, Novartis Pharma, PTC Therapeutics, and UniQure Biopharma. Within the past 36\u2009months, D.G.M. has been a scientific consultant and\/or received an honoraria or research contract from AMO Pharma, Dyne, F. Hoffman-La Roche, Function Rx, LoQus23, MOMA Therapeutics, Novartis, Ono Pharmaceuticals, Pfizer Pharmaceuticals, PTC Therapeutics, Rgenta Therapeutics, Sanofi, Sarepta Therapeutics Inc, Script Biosciences, Skyhawk Therapeutics, Triplet Therapeutics, and Vertex Pharmaceuticals. D.G.M. also had research contracts with AMO Pharma and Vertex Pharmaceuticals. D.G.M. is on the Scientific Advisory Board of the Myotonic Dystrophy Foundation and EuroDyMA (European Dystrophia Myotonica Association), is a scientific adviser to the Myotonic Dystrophy Support Group, and is a vice president for research of Muscular Dystrophy UK. G.B. is the founder and chief executive officer (part time) of Function Rx ltd. The authors declare that they have no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}